Henlius Trastuzumab recibe la aprobación de la FDA en Estados Unidos

Posted on by

SHANGHAI, 6 de mayo de 2024 /PRNewswire/ — Henlius Biotech, Inc. (2696.HK) anunció que el socio comercial de la compañía, Accord BioPharma Inc. (la división especializada estadounidense de Intas Pharmaceuticals, Ltd.), recibió la aprobación de la Administración de Medicamentos y…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.